Amcor Free cash flow increased by 88.7% to -$42.00M in Q1 2026 compared to the prior quarter. Over 2 years (FY 2021 to FY 2024), Free cash flow shows a downward trend with a -8.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $711.00M | -$257.00M | $325.00M | $148.00M | $783.00M | -$412.00M | $788.00M | -$259.00M | $242.00M | $37.00M | $809.00M | -$414.00M | $894.00M | -$371.00M | -$42.00M |
| QoQ Change | — | -136.1% | +226.5% | -54.5% | +429.1% | -152.6% | +291.3% | -132.9% | +193.4% | -84.7% | >999% | -151.2% | +315.9% | -141.5% | +88.7% |
| YoY Change | — | — | — | — | +10.1% | -60.3% | +0.6% | +37.1% | — | — | +2.7% | -59.8% | +10.5% | +10.4% | — |